Preperation and In Vitro Evaluation of Solid Dispersions of Nimodipine Using PEG 4000 and PVP K30


Affiliations

  • International Medical University, Department of Pharmaceutics, School of Pharmacy and Health Sciences, Kuala Lumpur, Malaysia
  • International Medical University, Department of Pharmaceutics, School of Pharmacy and Health Sciences, Kuala Lumpur, Malaysia
  • Taylor's University College, School of Medicine, Kuala Lumpur, Malaysia

Abstract

Solid dispersions in water-soluble carriers have attracted considerable interest as a means of improving the dissolution rate, and hence possibly bioavailability, of a range of hydrophobic drugs. The aim of the present study was to improve the solubility and dissolution rate of a poorly water-soluble drug, nimodipine, by a solid dispersion technique. Solid dispersions were prepared by using polyethylene glycol 4000 (PEG- 4000) and polyvinylpyrrolidone K30 (PVPK30) in different drug-to-carrier ratios. The solid dispersions were prepared by melting method. Morphology of solid dispersions was characterised by scanning electron microscope. The pure drug, physical mixtures and solid dispersions were characterized by in vitro dissolution study. Dissolution characteristics were determined by using pH 4.5 acetate buffer containing 0.3% SDS. The very slow dissolution rate was observed for pure nimodipine and the dispersion of the drug in the polymers considerably enhanced the dissolution rate. This can be attributed to improved wettability and dispersibility, as well as decrease of the crystalline and increase of the amorphous fraction of the drug. Solid dispersions prepared with PEG-4000 and PVPK30 showed the highest improvement in wettability and dissolution rate of nimodipine. Even physical mixtures of nimodipine prepared with both polymers also showed better dissolution profile than that of pure nimodipine. In conclusion, dissolution of nimodipine can be enhanced by the use of hydrophilic carriers PEG-4000 and PVPK30.

Keywords

Nimodipine, PEG - 4000, PVP K30 , Solid Dispersions, Dissolution Enhancement.

Subject Discipline

Pharmacy and Pharmacology

Full Text:

References

Langley MS, Sorkin EM. Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 1989; 37: 669–99.

Mohr JP, Orgogozo JM, Harrison MJG, Hennerici M, Wahlgren NG, Gelmers HI. Meta-analysis of oral nimodipine trials in acute ischemic stroke. Cerebrovasc Dis 1994;4: 197–203.

Pantoni L, Bianchi C, Beneke M, Inzitari D, Wallin A, Erkinjuntti T. The Scandinavian multi-infarct dementia trial: a double-blind, placebocontrolled trial on nimodipine in multi-infarct dementia. J Neurol Sci 2000;175: 116–23.

Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitrodrug product dissolution and in vivo bioavailability. Pharm Res 1995;12: 413-20.

Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 2000;50: 179-88.

Alonso MJ, Maincent P, Garcie AT, VilaJato JL. A comparative biopharmaceutical study of fresh and ageing tolbutamideplyethylene glycos solid dispersions. Int J Pharm Sci 1983;72: 708–10.

Stavchansky S, Gowan W. Evaluation of the bioavailability of a solid dispersion of phenytoin in polyethylene glycol 6000 and a commercial phenytoin sodium capsule in the dog. J Pharm Sci 1984;73: 733–6.

Yakou S, Umehara K, Sonobe T, Nagai T, Sugihara M, Fukuyama Y. Particle size dependency of dissolution rate and human bioavailability of phenytoin in powders and phenytoin–polyethelyne glycol solid dispersions. Chem Pharm Bull 1984;31: 4130–6.

Arias MJ, Gines JM, Moyano JR, PerezMartinez JI, Rabasco AM. Influence of the preparation method of solid dispersions on their dissolution rate: study of triamtereneD-mannitol system. Int J Pharm 1995; 123: 25–31.

Kai T, Akiyama Y, Nomura S, Sato M. Oral absorption improvement of poorly soluble drug using solid dispersion technique. Chem Pharm Bull 1996;44: 568–71.

Otseika M, Onone M, Matsuda Y. Hygroscopic stability and dissolution properties of spray-dried solid dispersion of furosemide with Eudragit. J Pharm Sci 1996;82: 32–8.

Torrado S, Torrado S, Torrado J, Cadorniga R. Preparation, dissolution and characterization of albendazole solid dispersions. Int J Pharm 1996;140: 247–59.

Ahmad MA, Hridaya NB. Preparation and in vitro evaluation of solid dispersions of halofantrine. Int J Pharm 2002;235: 17-33.

Li-Ping R, Bo-Yang Y, Guang-Miao F, Dan-ni Z. Improving the solubility of ampelopsin. J Pharmaceutical and Biomedical Analysis 2005;38: 457-64.

Evangelos K, Emmanuel G, Michael PS, Konstantinos A, Dimitrios B. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug– polymer interactions. Eur J Pharm and Biopharm 2007;66: 334-47.

Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004;272: 1-10.

Van DMG, Augustijns P, Blaton N, Kinget R. Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 1998;164: 67–80.

Babu GVMM, Prasad CHDS, Murthy KVR. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine. Int J pharm 2002;234: 1-17.

Chowdary KPR, Murhty KVR, Prasad CHDS. Solid dispersions of nimodipine: physicochemical and dissolution rate studies. Ind drugs 1995; 32: 537-42.

Higuchi T, Connors KA. Phase solubility diagram. Adv Anal Chem Instrum 1965;4:117-212.

Zhonggui H, Dafang Z, Xiaoyan C, Xiaohong L, Xing T and Limei Z. Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation. European J Pharm Sci. 2004, 21(4): 487-91.

Buchi NN, Chowdary KPR, Murthy KVR, Hayman AR, Becket G. Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems. AAPS PharmSciTech. 2003, 4 (1) article 7:1-12.

Matsumoto T, Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly-(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinylacetate) in relation to indomethacin crystallization. Pharm Res 1999;16: 1722–28.


Refbacks

  • There are currently no refbacks.